Skip to main content

Gen-Probe Acquires GTI Diagnostics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe has acquired GTI Diagnostics, a privately held diagnostics firm focused on the transplant, blood banking, and specialty coagulation markets, for $53 million in cash.

Wisconsin-based GTI makes human leukocyte antigen antibody detection products that are sold by Gen-Probe under its Lifecodes brand. It also makes serological typing trays, enzyme immunoassays, a range of molecular typing products for donor-recipient matching and patient monitoring, and immunoassay products that measure a patient's immune response to Heparin and Factor VIII therapies.

The GTI business is complementary to Gen-Probe's Tepnel business. Gen-Probe acquired Tepnel in 2009 for around $132 million.

Gen-Probe purchased GTI from private equity firm Riverside Company and individual investors, including GTI's founders and management. It paid for the deal with cash on hand and expects the acquisition to be slightly accretive to its 2011 earnings per share.

"Acquiring GTI enables us to broaden and strengthen our transplant diagnostics business," Carl Hull, Gen-Probe's president and CEO, said in a statement. "In addition, the acquisition gives us access to growing coagulation and transfusion-related blood bank products that we can sell to our current customer base."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.